INS and Insulin resistance: Interestingly, conventional insulin resistance indices, such as the Homeostasis Model Assessment of Insulin Resistance (HOMA-IR), and insulin sensitivity indices, such as the Quantitative Insulin Sensitivity Check Index (QUICKI), remained unchanged after 3 months of GLP-1 receptor agonist therapy.